4 HIV drugs inhibit retrovirus tied to prostate cancer, chronic fatigue

04/1/2010 | Bloomberg Businessweek

U.S. researchers learned that four HIV medicines target the xenotropic murine leukemia virus-related virus, a retrovirus that possibly causes prostate cancer and chronic fatigue syndrome, when administered as combination therapies. The drug cocktails involving raltegravir, zidovudine, tenofovir disoproxil fumarate and a compound labeled L-00870812 "might also have the added benefit of delaying or even preventing the virus from mutating into forms that are drug-resistant," a study author said.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ